Skip to main content
HUONS CO., LTD. logo

HUONS CO., LTD. — Investor Relations & Filings

Ticker · 243070 ISIN · KR7243070000 KO Manufacturing
Open in API
Filings indexed 385 across all filing types
Latest filing 2022-02-16 Regulatory Filings
Country KR South Korea
Listing KO 243070

About HUONS CO., LTD.

https://www.huons.com/en

HUONS CO., LTD. is an integrated pharmaceutical and healthcare company founded in 1965. The company develops and manufactures a wide range of finished pharmaceutical products, medical solutions, and medical devices under cGMP standards. It was a pioneer in its domestic market, developing the first plastic ampule injections and local anesthetics. The company's research and development efforts focus on key therapeutic areas including ophthalmology, osteoarthritis, dermatology, wellness, and Central Nervous System (CNS) disorders. Its diversified portfolio also extends to bio products, eye drops, cosmetics, and health functional foods, aiming to provide comprehensive healthcare solutions.

Recent filings

Filing Released Lang Actions
[기재정정]공정거래자율준수프로그램운영현황
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from Huons regarding their 'Compliance Program (CP) Operation Status'. It details the 2021 performance and 2022 operational plans for their internal compliance and ESG management systems. It is a formal disclosure filed with a regulatory body (indicated by the 'Correction Report' header and the nature of the content), which falls under the category of general regulatory announcements for corporate governance and compliance reporting.
2022-02-16 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Huons) announcing a significant change in financial results (revenue or profit structure change of 15% or more). This is a standard regulatory disclosure requirement in the Korean market (DART system) for public companies to report preliminary financial performance before the final audit is completed. Since it provides key financial highlights and reasons for the variance, it fits the definition of an Earnings Release (ER). FY 2021
2022-02-16 Korean
전환가액의조정
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing regarding the adjustment of the conversion price for convertible bonds (CB) issued by Huons. It details the change in conversion price, the number of convertible shares, and the calculation methodology based on market price fluctuations. This type of disclosure is a standard corporate action related to capital structure and financing instruments, which falls under the 'Capital/Financing Update' category.
2022-02-14 Korean
공정거래자율준수프로그램운영현황
Governance Information Classification · 100% confidence The document is a report detailing the company's 'Compliance Program' (CP) operations, including ISO37001 certification, ethics training, and ESG management. It outlines past performance (2021) and future plans (2022). This type of disclosure regarding internal governance, ethics, and regulatory compliance programs falls under the 'Governance Information' category, as it describes the company's internal rules and compliance structure.
2022-01-27 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (FSS) and Korea Exchange. This is a standard regulatory filing used to disclose insider shareholdings and changes in ownership by company directors or major shareholders. In the provided classification schema, this corresponds to 'Director's Dealing' (DIRS), which covers reports of personal share transactions or ownership status by company directors and executives.
2022-01-07 Korean
[기재정정]현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a regulatory filing from Huons regarding a 'Decision on Cash/In-kind Dividends'. It specifically details the dividend amount per share, the dividend yield, and the total dividend amount, which are key components of a dividend announcement. While it is a correction filing (amendment), the core subject matter is the declaration of dividend details for shareholders. Therefore, it falls under the 'Notice of Dividend Amount' category.
2022-01-03 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.